Table 2 The fibrosis indexes of the study subjects in the PSM cohorts

APRI at baseline

0.23 [0.19–0.30]

0.22 [0.18–0.27]

0.052

APRI at follow-up time

0.30 [0.26–0.37]

0.25 [0.22–0.34]

< 0.001

P-value

< 0.001

< 0.001

Medium or high APRI at baseline

4 (2.6)

3 (1.9)

1.000

Medium or high APRI at follow-up time

15 (9.7)

4 (2.6)

0.009

P-value

0.009

1.000

FIB-4 at baseline

0.99 [0.79–1.20]

0.93 [0.77–1.11]

0.095

FIB-4 at follow-up time

1.13 [0.92,1.35]

1.04 [0.87,1.30]

0.034

P-value

< 0.001

< 0.001

Medium or high FIB-4 at baseline

28 (18.2)

18 (11.7)

0.110

Medium or high FIB-4 at follow-up time

45 (29.2)

37 (24.0)

0.302

P-value

0.023

0.004